Becker's Healthcare September 16, 2024
Alexandra Murphy

Sanofi received FDA approval for a new manufacturing line to expand production of Beyfortus, a preventive therapy for respiratory syncytial virus in infants.

Beyfortus is the first long-acting monoclonal antibody approved by the FDA to prevent RSV-related lower respiratory tract disease in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, FDA, Govt Agencies, Pharma / Biotech
1st gene therapy delivered directly into brain approved
How HHS, FDA, and CDC Can Influence U.S. Vaccine Policy
Syndax Pharmaceuticals Leukemia Drug Wins a First-in-Class FDA Approval
New FDA rules for TV drug ads to take effect: 4 things to know
Artificial heart saves 4th patient

Share This Article